A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability

Clinical trial NCT00517543 · COMPLETED

Trial details

NCT number: NCT00517543
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)Rheumatoid Arthritis Atherosclerosis

Start date: 2007-08-01
Primary completion: 2007-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.